KLK3 and prostate carcinoma: We analyzed demographic and tumor characteristics of over 70,000 men who, according to data reported to the Surveillance, Epidemiology, and End Results (SEER) program (2004–2008), were diagnosed with prostate cancer based on an elevated PSA level and without other clinical signs of disease (stage T1cN0M0).